Lawrence Threlfall
Medical · Colorado Springs, CONPI 1609594456
Payments from drug & device makers
Across 86 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$361
- Novo Nordisk$189
- Boehringer Ingelheim$145
- Pfizer$124
- Seqirus USA Inc$106
- Astellas Pharma US Inc$83
- plus $707 from 22 others
What the payments were for
- Food & beverage$1,714100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $361 |
| Novo Nordisk | 13 | $189 |
| Boehringer Ingelheim | 7 | $145 |
| Pfizer | 6 | $124 |
| Seqirus USA Inc | 5 | $106 |
| Astellas Pharma US Inc | 4 | $83 |
| AbbVie | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Viiv Healthcare Company | 3 | $61 |
| Alkermes, Inc. | 2 | $50 |
| Inspire Medical Systems, Inc. | 1 | $50 |
| Bayer | 3 | $48 |
| Amgen | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $39 |
| Lilly USA, LLC | 2 | $31 |
| Bausch Health US, LLC | 1 | $25 |
| Boston Scientific | 1 | $21 |
| Tonix Medicines, Inc. | 1 | $21 |
| Cranial Technologies, Inc | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| GSK | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Vertex | 1 | $17 |
| Exact Sciences | 1 | $15 |
| Corcept Therapeutics | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$109
How this compares
$1,714 in reported general payments places this provider in the 75th percentile of 766 medical providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 12 | $12,558 |
| Atorvastatin Calcium | 69 | $586 |
| Levothyroxine Sodium | 33 | $336 |
| Gabapentin | 17 | $321 |
| Duloxetine Hcl | 16 | $306 |
| Ezetimibe | 15 | $213 |
| Triamcinolone Acetonide | 11 | $195 |
| Amlodipine Besylate | 25 | $192 |
| Donepezil Hcl | 12 | $184 |
| Rosuvastatin Calcium | 17 | $183 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $174 |
| Lisinopril | 32 | $164 |
| Cyclobenzaprine Hcl | 13 | $162 |
| Tamsulosin Hcl | 13 | $156 |
| Famotidine | 11 | $135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $145 | $12,55812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 766 medical providers in Colorado.
Other medical in Colorado Springs
- Christen KutzColorado Springs$2.4M
- Kristin RyggColorado Springs$255K
- Michelle BarnettColorado Springs$138K
- Deanna JohnsonColorado Springs$41K
- David BrunkColorado Springs$18K
- Meghan CogswellColorado Springs$18K
- Amanda MixonFort Collins$342K
- Jordan MastDenver$247K
- John NovakAurora$173K
- Michael JacobsonFort Collins$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.